InDex Pharmaceuticals is attending the UEGW 2023 congress
October 5, 2023 – InDex Pharmaceuticals Holding AB (publ) will attend the United European Gastroenterology Week (UEGW), one of the world’s leading gastroenterology congresses. UEGW is taking place October 14-17, 2023 in Copenhagen.InDex Pharmaceuticals will be present at booth #C3-84 in the exhibition hall at the Bella Center. InDex’s team members will be available on site to provide information about cobitolimod and the ongoing phase III program CONCLUDE, which is evaluating the Toll-like receptor 9 agonist cobitolimod, as a potential novel treatment for moderate to severe left-sided
Kiilto has been awarded a silver level rating from the EcoVadis assessment on 21 sustainability criteria focused on four key performance areas: Environment, Labour & Human Rights, Ethics, and Sustainable Procurement. This result places Kiilto in the top 25% of companies rated by EcoVadis.EcoVadis is the world’s largest and most trusted provider of business sustainability ratings, creating a global network of more than 100,000+ rated companies. Its methodology is based on internationally recognized principles and standards such as Global Reporting Initiative (GRI), UN
Finnish Tampere Tramway Ltd., the City of Tampere, and the Municipality of Pirkkala, have appointed AFRY as part of an alliance to deliver on the third stage of the Tampere tram network extension, engaging several of AFRY’s disciplines.AFRY, together with YIT, NRC and Sweco, and the clients, will form an alliance, which is responsible for the development phase of the third stage of the Tampere tramway project. The implementation planning will commence in October 2023.
The project includes street plans for the tram streets, an implementation plan from Linnainmaa, Tampere, to Suuppa,
